RxSight (RXST) Change in Account Payables (2020 - 2026)
RxSight (RXST) posted Change in Account Payables of $1.6 million for Q1 2026, down 28.45% on a QoQ basis from $2.2 million in Q4 2025, and down 29.16% year-over-year from $2.2 million in Q1 2025.
RxSight (RXST) Change in Account Payables (2020 - 2026) Analysis & Trends
RxSight's Change in Account Payables history runs 7 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly Change in Account Payables fell 29.16% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22000.0 (down 101.1% YoY) and the FY2025 annual result came in at $627000.0, down 33.72% from the prior year.
- Change in Account Payables was $1.6 million for Q1 2026 at RxSight, down from $2.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.2 million in Q1 2025 and bottomed at -$3.7 million in Q2 2025.
- A 5-year average of $296176.5 and a median of $161000.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables tumbled 1779.21% — and 2025, when it surged 1800.0%.
- RxSight's Change in Account Payables stood at -$1.7 million in 2022, then soared by 90.68% to -$158000.0 in 2023, then jumped by 173.42% to $116000.0 in 2024, then jumped by 1800.0% to $2.2 million in 2025, then declined by 28.45% to $1.6 million in 2026.
- Business Quant data shows RXST's Change in Account Payables at $1.6 million in Q1 2026, $2.2 million in Q4 2025, and -$86000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | -86,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | -387,000.00 |
| Jun 30, 2024 | -387,000.00 |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | -158,000.00 |
| Dec 31, 2023 | -158,000.00 |